Fetal, infant, and maternal toxicity of zidovudine (azidothymidine) administered throughout pregnancy in Macaca nemestrina

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 1, 1998, Pages 27-38

  Ha, James C ^a   Nosbisch, Connie ^a   Abkowitz, Janis L ^b   Conrad, Suzanne H ^a   Mottet, N Karle ^a   Ruppenthal, Gerald C ^a   Robinette, Renee ^a   Sackett, Gene P ^a   Unadkat, Jashvant D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

AZT; Fetal toxicity; Hematologic toxicity; Macaca nemestrina; Maternal toxicity; Pregnancy

Indexed keywords

PLACEBO; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATHETERIZATION; FETOTOXICITY; INFECTION RISK; LEUKOCYTE COUNT; MACACA; MACROCYTIC ANEMIA; NONHUMAN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; STIMULUS RESPONSE; VERTICAL TRANSMISSION;

ANIMALIA; MACACA; MACACA NEMESTRINA; RNA VIRUSES;

EID: 0032080304     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199805010-00005     Document Type: Article

References (42)

1. Oxtoby MJ. Vertically acquired HIV infection in the United States. In Pizzo PA, Wilfert CM, eds. Pediatric AIDS: the challenge of HIV infection in infants, children, and adolescents, 2nd ed. Baltimore: Williams & Wilkins, 1994:3-20.
2. Oxtoby MJ. Perinatally acquired human immunodeficiency virus infection. Pediat Infect Dis J 1990;9:609-19.
3. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
4. Boyer PI, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-1. JAMA 1994;271:1925-30.
5. Carcassi C, Chiappe F, Lecca U, et al. A study of 9 infants born from HIV-1 positive mothers who continued treatment with AZT during pregnancy. VII International Conference on AIDS, Florence, 1991:353.
6. Chavanet P, Diquet B, Waldner A, Portier H. Perinatal pharmacokinetics of zidovudine. N Engl J Med 1989;321:1548-9.
7. Sperling RS, Stratton P, O'Sullivan MJ, et al. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N Engl J Med 1992;326:857-61.
8. Sperling RS, Roboz J, Dische R, Silides D, Holzman I, Jew E. Zidovudine pharmacokinetics during pregnancy. Am J Perinatal 1992;9:247-9.
9. Viscarello RR, DeGennaro NJ, Hobbins JC. Preliminary experience with the use of zidovudine (AZT) during pregnancy [abstract]. Am J Obstet Gynecol 1991;164:248.
10. Antiretroviral Pregnancy Registry/Centers for Disease Control. Birth outcomes following zidovudine therapy in pregnant women. MMWR Morbid Mortal Wkly Rep 1994;43:409,415-6.
11. Ayers KM. Preclinical toxicology of zidovudine. Am J Med 1988;85(Suppl 2A):186-8.
12. Sieh E, Coluzzi ML, de Angelis MGC, et al. The effects of AZT and DDI on pre- and postimplantation mammalian embryos: an in vivo and in vitro study. AIDS Res Hum Retroviruses 1992;8:639-49.
13. Toltzis P, Marx CM, Kleinman N, Levine EM, Schmidt EV. Zidovudine-associated embryonic toxicity in mice. J Infect Dis 1991; 163:1212-8.
14. Lopez-Anaya, A, Unadkat ID, Schumann LA, Smith AL. Pharrnacokinetics of zidovudine (azidothymidine). I. Transplacental transfer. J AIDS 1990;3:959-64.
15. Ha JC, Nosbisch C, Conrad SH, et al. Fetal toxicity of zidovudine (azidothymidine) in Macaca nemestrina: preliminary observations. J AIDS 1994;7:154-7.
16. Morton WR, Knitter GH, Smith PM, Susor TG, Schmitt K. Alternatives to chronic restraint of nonhuman primates. J Am Vet Med Assoc 1987;191:1282-6.
17. Blakley GA, Blaine CR, Morton WR. Correlation of perineal detumescence and ovulation in the pigtail macaque (Macaca nemestrina). Lab Anim Sci 1977;27:352-5.
18. Conrad S, Ha JC, Lohr C, Sackett G. Ultrasonic assessment of fetal growth in the pigtailed macaque (Macaca nemestrina). Am J Primatol 1995;36:15-35.
19. Unadkat JD, Crosby SS, Wang JP, Hertel CC. A simple and rapid high-performance liquid chromatographic assay for zidovudine (azidothymidine) in plasma and urine. J Chromat 1988;430:420-3.
20. Ruppenthal GC, Sackett GP. Research protocol and technician's manual: a guide to the care, feeding, and evaluation of infant monkeys, 2nd ed. Seattle: Infant Primate Research Laboratory, University of Washington, 1992.
21. Clarren SK, Astley SJ, Bowden DM. Physical anomalies and developmental delays in nonhuman primate infants exposed to weekly doses of ethanol during gestation. Teratology 1988;37: 561-9.
22. Piaget J. The construction of reality in the child. New York: Basic Books, Inc., 1954:3-96.
23. Tartaglione TA, Collier AC, Opheim K, Gianola FG, Benedetti J, Corey L. Pharmacokinetic evaluations of low- and high-dose zidovodine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection. Antimicrob Agents Chemother 1991;35:2225-31.
24. Morse GD, Portmore A, Olson J, Taylor C, Plank C, Reichman RC. Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection. Antimicrob Agents Chemother 1990;34:394-7.
25. Watts DH, Brown ZA, Tartaglione T, et al. Pharmacokinetic disposition of zidovudine during pregnancy. J Infect Dis 1991;163: 226-32.
26. Lyman WD, Tanaka KE, Kress Y, Rashbaum WK, Rubinstein A, Soeiro R. Zidovudine concentrations in human fetal tissue: implications for perinatal AIDS. Lancet 1990;335:1280-1.
27. Gillet JY, Bongain A, Abrar D, Garraffo R, Lapalus P. Etude preliminaire sur le passage transplacentaire de l'AZT (Retrovir). J Gynecol Obstet Biol Reprod 1990;19:177-80.
28. Gelmon K, Montaner JSG, Fanning M, et al. Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial. AIDS 1989; 3:555-61.
29. 9/L or less. Arch Intern Med 1992;152:2286-92.
30. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med 1990;322:941-9.
31. Collier AC, Bozzette S, Coombs RW, et al. A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N Engl J Med 1990;323:1015-21.
32. Allen JR, Ahlgren SA. A comparative study of the hematologic changes in pregnancy in the Macaca mulatta monkey and the human female. Am J Obstet Gynecol 1968;100:894-903.
33. Fujiwara T, Suzaki Y, Yoshioka Y, Honjo S. Hematological changes during pregnancy and postpartum period in cynomolgus monkeys (Macaca fascicularis). Exp Animals 1974;23:137-46.
34. O'Sullivan MJ, Boyer PJJ, Scott GB, et al. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Am J Obstet Gynecol 1993;168: 1510-6.
35. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987;317:192-7.
36. Switzer JW, Valerio DA, Martin DJP, Valerio MG, Rininger BF. Hematologic changes associated with pregnancy and parturition in Macaca mulatta. Lab Anim Care 1970;20:930-9.
37. Montaner JSG, Le T, Fanning M, et al. The effect of zidovudine on platelet count in HIV-infected individuals. J AIDS 1990;3:565-70.
38. Ferrazin A, de Maria A, Gotta C, et al. Zidovudine therapy of HIV-1 infection during pregnancy: assessment of the effect on the newborns. J AIDS 1993;6:376-9.
39. Fahrenbruch CE, Burbacher TM, Sackett GP. Gross placental morphology and pregnancy outcome in Macaca nemestrina. In Ruppenthal GC, ed. Nursery care of nonhuman primates. New York: Plenum Press, 1979:27-34.
40. Fox H. A contemporary view of the human placenta. Midwifery 1991;7:31-9.
41. Thomson AM, Billewicz WZ, Hytten FE. The weight of the placenta in relation to birthweight. J Obstet Gynaecol Br Cwlth 1969; 76:865-72.
42. Pollitt E, Soemantri AG, Yunis F, Scrimshaw NS. Cognitive effects of iron-deficiency anemia. Lancet 1985;1:158.